400客服电话
购买数据产品
400-9696-311 转1
定制咨询业务
400-9696-311 转2
数据与AI定制业务
400-9696-311 转3
商务合作及其他问题
400-9696-311 转4
投诉及建议
400-9696-311 转5
ChiCTR1900021581
尚未开始
/
/
/
2019-02-28
/
/
Study on malignant tumour
微生物群與癌症治療
癌症治療後口腔和腸道微生物群變化的觀察性研究
000
Primary objective: 1. Delineate changes in gut and oral microbial community profiles of cancer therapy patients before and after therapy. Secondary objectives: 2. Correlate baseline gut and oral microbial community profiles with the origin of primary tumours; 3. Correlate changes in gut and oral microbial community profiles with the development of toxicity; 4. Compare gut and oral microbial community profiles between cancer patients and age-/sex-matched healthy controls (to be recruited under another study with ethics approval obtained).
析因分组（即根据危险因素或暴露因素分组）
Ⅰ期
N/A
Open
香港中文大學
/
100;50;150
/
2019-03-05
2021-03-04
/
1. Chinese people aged 18 or above, no upper age limit; 3. Having newly diagnosed malignant tumour; 4. A new case referred to the Oncology Centre for management.；
请登录查看1. Patients who have previously received cancer therapy; 2. Patients who will receive concurrent radiotherapy; 3. Patients with conditions rendering them incapable to answer questionnaires or provide oral and stool samples; 4. Subjects who are unable to give consent.；
请登录查看香港中文大學微生物學系
000
德琪医药2026-07-20
动脉网-最新2026-07-20
药精通Bio2026-07-20
求实药社2026-07-20
求实药社2026-07-20
康方生物Akeso2026-07-20
干细胞与外泌体2026-07-20
加科思2026-07-20
良医汇肿瘤资讯2026-07-19
GLP1减重宝典2026-07-19
400-9696-311 转1
400-9696-311 转3
400-9696-311 转4
400-9696-311 转5
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
